Molecular cytogenetic aberrations in CD30+ anaplastic large cell lymphoma cell lines

被引:12
|
作者
Gogusev, J
Telvi, L
Nezelof, C
机构
[1] Hop Necker Enfants Malad, INSERM U507, F-75015 Paris, France
[2] Hop St Vincent de Paul, Grp Pathol Pediat, Lab Cytogenet, F-75674 Paris, France
关键词
D O I
10.1016/S0165-4608(02)00589-7
中图分类号
R73 [肿瘤学];
学科分类号
100214 ;
摘要
Anaplastic large cell lymphomas (ALCL) in children represent a heterogeneous group of neoplasms with regard to the cell lineages involved. The chromosomal 5q35 breakpoint (bp) and the expression of the NPM/ALK fusion gene are the most remarkable molecular cytogenetic features of these malignancies. To identify new locations of ALCL-related oncogenes, comparative genomic hybridization (CGH) was applied to three ALCL cell lines (SU-DHL-1, Karpas 299, and DEL) exhibiting the 5q35 bp and expressing the NPM/ALK transcript. The CGH profiles were compared with those obtained with DNA from U937, HL-60 cells, and altered lymph nodes from two children with ALCL. Significant DNA copy number gains and/or losses were observed on several chromosomes in all ALCL cell lines. Distinct amplicons were detected on 1q21similar toq44 (DEL), 7q12 (SU-DHL-1), and 1q12similar toq22 (Karpas 299) regions. The NPM/ALK fusion gene was confirmed by fluorescence in situ hybridization (FISH) analysis in more than 80% of interphase nuclei and metaphase spreads. Enhanced expression of TGF-beta2 and c-MET candidate genes located at the amplified regions was revealed in DEL and SU-DHL1 cell lines by Northern blot analysis. These findings delineate chromosomal imbalances in ALCL-derived cell lines in parallel with high level of amplification covering target DNA sequences, which could play a role in ALCL pathogenesis. (C) 2002 Elsevier Science Inc. All rights reserved.
引用
收藏
页码:95 / 101
页数:7
相关论文
共 50 条
  • [31] CD30+ anaplastic large cell lymphoma:: a review of its histopathologic, genetic, and clinical features
    Stein, H
    Foss, HD
    Dürkop, H
    Marafioti, T
    Delsol, G
    Pulford, K
    Pileri, S
    Falini, B
    BLOOD, 2000, 96 (12) : 3681 - 3695
  • [32] Multifocal primary cutaneous CD30+ anaplastic large cell lymphoma responsive to thalidomide: the molecular mechanism and the clinical application
    Lee, J-H.
    Cheng, A-L.
    Lin, C-W.
    Kuo, S-H.
    BRITISH JOURNAL OF DERMATOLOGY, 2009, 160 (04) : 887 - 889
  • [33] CD30+ anaplastic large-cell lymphoma, null type, with signet-ring appearance
    Falini, B
    Liso, A
    Pasqualucci, L
    Flenghi, L
    Ascani, S
    Pileri, S
    Bucciarelli, E
    HISTOPATHOLOGY, 1997, 30 (01) : 90 - 92
  • [34] A Case Report of Primary Cutaneous CD30+ Anaplastic Large Cell Lymphoma Which Responded to Radiotherapy
    Turkmen, Meltem
    Ertam, Ilgen
    Kandiloglu, Gulsen
    Alper, Sibel
    TURK DERMATOLOJI DERGISI-TURKISH JOURNAL OF DERMATOLOGY, 2007, 1 (01): : 21 - 23
  • [35] Glatiramer acetate-associated, CD30+, primary, cutaneous, anaplastic large-cell lymphoma
    Madray, Monica M.
    Greene, John F., Jr.
    Butler, David F.
    ARCHIVES OF NEUROLOGY, 2008, 65 (10) : 1378 - 1379
  • [36] Posttransplant lymphoproliferative disorder presenting as CD30+, ALK+, anaplastic large cell lymphoma in a child
    Sebire, NJ
    Malone, M
    Ramsay, AD
    PEDIATRIC AND DEVELOPMENTAL PATHOLOGY, 2004, 7 (03) : 290 - 293
  • [37] Central nervous system involvement at diagnosis in a case of pediatric CD30+ anaplastic large cell lymphoma
    Kaplinsky, C
    Toren, A
    Neumann, Y
    Mandel, M
    Kenet, G
    Sharon, N
    Rechavi, G
    Biniaminov, M
    Rubanov, V
    Rosenthal, E
    Rosner, E
    Mark, Z
    Amariglio, N
    BrokSimoni, F
    MEDICAL AND PEDIATRIC ONCOLOGY, 1997, 28 (02): : 132 - 135
  • [38] Response of CD30+ large cell lymphoma of skin to bexarotene
    Keung, YK
    Woodruff, R
    Sangueza, O
    LEUKEMIA & LYMPHOMA, 2002, 43 (05) : 1153 - 1154
  • [39] Glatiramer acetate-associated CD30+ primary cutaneous anaplastic large-cell lymphoma
    Madray, Monica
    Butler, David E.
    Greene, John
    JOURNAL OF THE AMERICAN ACADEMY OF DERMATOLOGY, 2009, 60 (03) : AB128 - AB128
  • [40] p16(INK4) and p53 mutations in anaplastic large cell lymphoma (CD30+) cell lines.
    Chan, A
    Portwine, C
    Lees, J
    Lorenzana, A
    Malkin, D
    BLOOD, 1995, 86 (10) : 2893 - 2893